178 related articles for article (PubMed ID: 37996637)
1. Comprehensive Multiomics Analyses Establish the Optimal Prognostic Model for Resectable Gastric Cancer : Prognosis Prediction for Resectable GC.
Guo S; Wang E; Wang B; Xue Y; Kuang Y; Liu H
Ann Surg Oncol; 2024 Mar; 31(3):2078-2089. PubMed ID: 37996637
[TBL] [Abstract][Full Text] [Related]
2. Mutational and Transcriptional Characterization Establishes Prognostic Models for Resectable Lung Squamous Cell Carcinoma.
Liu Y; Duan J; Zhang F; Liu F; Luo X; Shi Y; Lei Y
Cancer Manag Res; 2023; 15():147-163. PubMed ID: 36824152
[TBL] [Abstract][Full Text] [Related]
3. Exploring biomarkers for prognosis and neoadjuvant chemosensitivity in rectal cancer: Multi-omics and ctDNA sequencing collaboration.
Jiang XF; Zhang BM; Du FQ; Guo JN; Wang D; Li YE; Deng SH; Cui BB; Liu YL
Front Immunol; 2022; 13():1013828. PubMed ID: 36569844
[TBL] [Abstract][Full Text] [Related]
4. Identification of three lncRNA-related prognostic signatures in gastric cancer by integrated multi-omics analysis.
Jiang H; Wang J; Song Y; Chen J; Dong L; Xu Q; Cao R; Wang Y; Xu X; Zhang X; Kong F; Guan M; Deng X
Epigenomics; 2023 Dec; 15(24):1293-1308. PubMed ID: 38126139
[No Abstract] [Full Text] [Related]
5. Identification of cuproptosis-related subtypes, construction of a prognosis model, and tumor microenvironment landscape in gastric cancer.
Wang J; Qin D; Tao Z; Wang B; Xie Y; Wang Y; Li B; Cao J; Qiao X; Zhong S; Hu X
Front Immunol; 2022; 13():1056932. PubMed ID: 36479114
[TBL] [Abstract][Full Text] [Related]
6. Association of MUC16 Mutation With Tumor Mutation Load and Outcomes in Patients With Gastric Cancer.
Li X; Pasche B; Zhang W; Chen K
JAMA Oncol; 2018 Dec; 4(12):1691-1698. PubMed ID: 30098163
[TBL] [Abstract][Full Text] [Related]
7. Identification of 5 Gene Signatures in Survival Prediction for Patients with Lung Squamous Cell Carcinoma Based on Integrated Multiomics Data Analysis.
Ma H; Tong L; Zhang Q; Chang W; Li F
Biomed Res Int; 2020; 2020():6427483. PubMed ID: 32596344
[TBL] [Abstract][Full Text] [Related]
8. Mutational and transcriptional alterations and clinicopathological factors predict the prognosis of stage I hepatocellular carcinoma : Prediction of stage I HCC prognosis.
Li Z; Gao H; Zhang X; Liu Q; Chen G
BMC Gastroenterol; 2022 Sep; 22(1):427. PubMed ID: 36153509
[TBL] [Abstract][Full Text] [Related]
9. Development and validation of prognostic markers in sarcomas base on a multi-omics analysis.
Song Y; Yang K; Sun T; Tang R
BMC Med Genomics; 2021 Jan; 14(1):31. PubMed ID: 33509178
[TBL] [Abstract][Full Text] [Related]
10. Construction of a Comprehensive Multiomics Map of Hepatocellular Carcinoma and Screening of Possible Driver Genes.
Liu Z; Lin Y; Gao X; Mai R; Piao X; Ye J; Liang R
Front Genet; 2020; 11():634. PubMed ID: 32670354
[No Abstract] [Full Text] [Related]
11. Cancer functional states-based molecular subtypes of gastric cancer.
Zhou Q; Yuan Y; Lu H; Li X; Liu Z; Gan J; Yue Z; Wu J; Sheng J; Xin L
J Transl Med; 2023 Feb; 21(1):80. PubMed ID: 36739412
[TBL] [Abstract][Full Text] [Related]
12. Predictive test for chemotherapy response in resectable gastric cancer: a multi-cohort, retrospective analysis.
Cheong JH; Yang HK; Kim H; Kim WH; Kim YW; Kook MC; Park YK; Kim HH; Lee HS; Lee KH; Gu MJ; Kim HY; Lee J; Choi SH; Hong S; Kim JW; Choi YY; Hyung WJ; Jang E; Kim H; Huh YM; Noh SH
Lancet Oncol; 2018 May; 19(5):629-638. PubMed ID: 29567071
[TBL] [Abstract][Full Text] [Related]
13. DNA methylation signatures associated with prognosis of gastric cancer.
Dai J; Nishi A; Li ZX; Zhang Y; Zhou T; You WC; Li WQ; Pan KF
BMC Cancer; 2021 May; 21(1):610. PubMed ID: 34034702
[TBL] [Abstract][Full Text] [Related]
14. Molecular classification reveals the diverse genetic and prognostic features of gastric cancer: A multi-omics consensus ensemble clustering.
Hu X; Wang Z; Wang Q; Chen K; Han Q; Bai S; Du J; Chen W
Biomed Pharmacother; 2021 Dec; 144():112222. PubMed ID: 34607103
[TBL] [Abstract][Full Text] [Related]
15. Bioinformatic analysis of the prognostic value of ZNF860 in recurrence-free survival and its potential regulative network in gastric cancer.
Pan HX; Bai HS; Guo Y; Cheng ZY
Eur Rev Med Pharmacol Sci; 2019 Jan; 23(1):162-170. PubMed ID: 30767193
[TBL] [Abstract][Full Text] [Related]
16. Identification of novel prognostic biomarkers by integrating multi-omics data in gastric cancer.
Liu N; Wu Y; Cheng W; Wu Y; Wang L; Zhuang L
BMC Cancer; 2021 Apr; 21(1):460. PubMed ID: 33902514
[TBL] [Abstract][Full Text] [Related]
17. A novel scoring system for gastric cancer risk assessment based on the expression of three CLIP4 DNA methylation-associated genes.
Hu C; Zhou Y; Liu C; Kang Y
Int J Oncol; 2018 Aug; 53(2):633-643. PubMed ID: 29901187
[TBL] [Abstract][Full Text] [Related]
18. A nomogram model based on the number of examined lymph nodes-related signature to predict prognosis and guide clinical therapy in gastric cancer.
Li H; Lin D; Yu Z; Li H; Zhao S; Hainisayimu T; Liu L; Wang K
Front Immunol; 2022; 13():947802. PubMed ID: 36405735
[TBL] [Abstract][Full Text] [Related]
19. Multi-Omics analysis identifies a lncRNA-related prognostic signature to predict bladder cancer recurrence.
Xu Z; Chen H; Sun J; Mao W; Chen S; Chen M
Bioengineered; 2021 Dec; 12(2):11108-11125. PubMed ID: 34738881
[TBL] [Abstract][Full Text] [Related]
20. Single-cell multi-omics sequencing reveals chromosome copy number inconsistency between trophectoderm and inner cell mass in human reconstituted embryos after spindle transfer.
Zhong W; Shen K; Xue X; Wang W; Wang W; Zuo H; Guo Y; Yao S; Sun M; Song C; Wang Q; Ruan Z; Yao X; Shang W
Hum Reprod; 2023 Nov; 38(11):2137-2153. PubMed ID: 37766497
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
